These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2539321

  • 1. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft.
    Yousem SA, Randhawa P, Locker J, Paradis IL, Dauber JA, Griffith BP, Nalesnik MA.
    Hum Pathol; 1989 Apr; 20(4):361-9. PubMed ID: 2539321
    [Abstract] [Full Text] [Related]

  • 2. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B, Yousem SA.
    Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068
    [Abstract] [Full Text] [Related]

  • 3. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
    Abu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD.
    Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
    [Abstract] [Full Text] [Related]

  • 4. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
    Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DL.
    J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
    [Abstract] [Full Text] [Related]

  • 5. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE.
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [Abstract] [Full Text] [Related]

  • 6. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
    Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.
    Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700
    [Abstract] [Full Text] [Related]

  • 7. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 8. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients.
    Haque T, Thomas JA, Falk KI, Parratt R, Hunt BJ, Yacoub M, Crawford DH.
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1169-72. PubMed ID: 8683203
    [Abstract] [Full Text] [Related]

  • 9. Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.
    Hopwood PA, Brooks L, Parratt R, Hunt BJ, Bokhari M, Thomas JA, Yacoub M, Crawford DH.
    Transplantation; 2002 Jul 27; 74(2):194-202. PubMed ID: 12151731
    [Abstract] [Full Text] [Related]

  • 10. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients.
    Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J.
    Am J Clin Pathol; 1989 Aug 27; 92(2):177-85. PubMed ID: 2547308
    [Abstract] [Full Text] [Related]

  • 11. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 27; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
    Angel LF, Cai TH, Sako EY, Levine SM.
    Ann Transplant; 2000 Jun 27; 5(3):26-30. PubMed ID: 11147026
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys.
    Schmidtko J, Wang R, Wu CL, Mauiyyedi S, Harris NL, Della Pelle P, Brousaides N, Zagachin L, Ferry JA, Wang F, Kawai T, Sachs DH, Cosimi BA, Colvin RB.
    Transplantation; 2002 May 15; 73(9):1431-9. PubMed ID: 12023621
    [Abstract] [Full Text] [Related]

  • 14. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.
    Transpl Infect Dis; 2010 Aug 01; 12(4):342-6. PubMed ID: 20030794
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.
    Courtwright AM, Burkett P, Divo M, Keller S, Rosas IO, Trindade A, Mody GN, Singh SK, El-Chemaly S, Camp PC, Goldberg HJ, Mallidi HR.
    Ann Thorac Surg; 2018 Feb 01; 105(2):441-447. PubMed ID: 29223419
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 17. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.
    Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, Bryan CL.
    Chest; 1999 Nov 27; 116(5):1273-7. PubMed ID: 10559086
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.
    Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.
    Clin Transplant; 2017 Jul 27; 31(7):. PubMed ID: 28383790
    [Abstract] [Full Text] [Related]

  • 19. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 27; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 20. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec 27; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.